The Drugs Controller General of India (DCGI) on Monday granted final approval to Biological E’s COVID-19 vaccine Corbevax, for children between 12-18 years of age in India.
Till now India has been administering Bharat Biotech’s Covaxin to teens between 15 and 18 years old since January 3.
The EUA, short for emergency use authorisation, for Corbevax’s restricted use in emergency among adults was cleared by the regulator Drugs Controller General of India in December 2019.